{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:25:25Z","timestamp":1784759125162,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.lpm.2021.104092","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T07:20:21Z","timestamp":1635319221000},"page":"104092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Differential diagnosis of multiple sclerosis"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1129-0050","authenticated-orcid":false,"given":"Julien J.","family":"Cavanagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7969-8346","authenticated-orcid":false,"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2021.104092_bib0001","article-title":"Challenges in multiple sclerosis diagnosis: Misunderstanding and misapplication of the McDonald criteria","author":"Solomon","year":"2020","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.lpm.2021.104092_bib0002","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104092_bib0003","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","article-title":"A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease","volume":"46","author":"Weinshenker","year":"1999","journal-title":"Ann Neurol"},{"issue":"1-2","key":"10.1016\/j.lpm.2021.104092_bib0004","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2012.02.017","article-title":"Variable results after rituximab in neuromyelitis optica","volume":"317","author":"Lindsey","year":"2012","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.lpm.2021.104092_bib0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneurol.2011.216","article-title":"Failure of natalizumab to prevent relapses in neuromyelitis optica","volume":"69","author":"Kleiter","year":"2012","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1016\/j.lpm.2021.104092_bib0006","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N Engl J Med"},{"issue":"10206","key":"10.1016\/j.lpm.2021.104092_bib0007","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(19)31817-3","article-title":"Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2\/3 trial","volume":"394","author":"Cree","year":"2019","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.lpm.2021.104092_bib0008","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1056\/NEJMoa1901747","article-title":"Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder","volume":"381","author":"Yamamura","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lpm.2021.104092_bib0009","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.lpm.2021.104092_bib0010","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"Pt 4","key":"10.1016\/j.lpm.2021.104092_bib0011","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/brain\/awf087","article-title":"Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance","volume":"125","author":"Kupersmith","year":"2002","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.lpm.2021.104092_bib0012","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ana.410410315","article-title":"Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis","volume":"41","author":"Jacobs","year":"1997","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.lpm.2021.104092_bib0013","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.50.3.708","article-title":"Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings","volume":"50","author":"Soderstrom","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.lpm.2021.104092_bib0014","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1474-4422(05)00992-0","article-title":"The neuro-ophthalmology of multiple sclerosis","volume":"4","author":"Frohman","year":"2005","journal-title":"Lancet Neurol"},{"issue":"Pt 2","key":"10.1016\/j.lpm.2021.104092_bib0015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION)","volume":"126","author":"Kidd","year":"2003","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.lpm.2021.104092_bib0016","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-013-6957-4","article-title":"Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported","volume":"261","author":"Petzold","year":"2014","journal-title":"J Neurol"},{"issue":"1-2","key":"10.1016\/j.lpm.2021.104092_bib0017","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2010.07.011","article-title":"Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis","volume":"298","author":"Jarius","year":"2010","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.lpm.2021.104092_bib0018","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12974-018-1335-x","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies","volume":"15","author":"Lee","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.lpm.2021.104092_bib0019","article-title":"Hyperacute corticosteroid treatment of optic neuritis at the onset of pain may prevent visual loss: a case series","volume":"2011","author":"Plant","year":"2011","journal-title":"Mult Scler Int"},{"issue":"1","key":"10.1016\/j.lpm.2021.104092_bib0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3129\/i09-238","article-title":"Intravenous immunoglobulin in recurrent-relapsing inflammatory optic neuropathy","volume":"45","author":"Stiebel-Kalish","year":"2010","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104092_bib0021","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bjo.2006.111666","article-title":"The use of infliximab in ocular inflammation","volume":"92","author":"Prendiville","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104092_bib0022","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1755-3768.2008.01193.x","article-title":"Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review","volume":"87","author":"Lin","year":"2009","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104092_bib0023","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"64","author":"Barile-Fabris","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"44","key":"10.1016\/j.lpm.2021.104092_bib0024","doi-asserted-by":"crossref","first-page":"e5194","DOI":"10.1097\/MD.0000000000005194","article-title":"Optic neuritis as an initial presentation of primary Sj\u00f6gren syndrome: a case report and literature review","volume":"95","author":"Sun","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2021.104092_bib0025","article-title":"Bilateral retrobulbar optic neuritis as the first manifestation of neuro-behcet disease","author":"Jari","year":"2020","journal-title":"Case Rep Rheumatol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104092_bib0026","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","article-title":"Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG","volume":"54","author":"Cross","year":"2003","journal-title":"Ann Neurol"},{"issue":"22","key":"10.1016\/j.lpm.2021.104092_bib0027","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1212\/WNL.0000000000002723","article-title":"Acute disseminated encephalomyelitis in 228 patients: a retrospective, multicenter US study","volume":"86","author":"Koelman","year":"2016","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.lpm.2021.104092_bib0028","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1590\/0004-282x20200186","article-title":"Acute disseminated encephalomyelitis in COVID-19: presentation of two cases and review of the literature","volume":"78","author":"Lopes","year":"2020","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.lpm.2021.104092_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102753","article-title":"Association of COVID-19 and acute disseminated encephalomyelitis (ADEM) in the absence of pulmonary involvement","author":"Shahmirzaei","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.lpm.2021.104092_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-239597","article-title":"Acute disseminated encephalomyelitis (ADEM) associated with COVID-19","volume":"13","author":"Langley","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.lpm.2021.104092_bib0031","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00234-020-02571-0","article-title":"Acute disseminated encephalomyelitis in a COVID-19 pediatric patient","volume":"63","author":"de Miranda Henriques-Souza","year":"2021","journal-title":"Neuroradiology"},{"issue":"11","key":"10.1016\/j.lpm.2021.104092_bib0032","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/cid\/ciw607","article-title":"Acute demyelinating events following vaccines: a case-centered analysis","volume":"63","author":"Baxter","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.lpm.2021.104092_bib0033","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2021.104092_bib0034","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2458-14-111","article-title":"Epidemiological characteristics of acute disseminated encephalomyelitis in Nanchang, China: a retrospective study","volume":"14","author":"Xiong","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.lpm.2021.104092_bib0035","unstructured":"Anilkumar, A.C., L.A. Foris, and P. Tadi, Acute disseminated encephalomyelitis, in StatPearls. 2020: Treasure Island (FL)."},{"issue":"10","key":"10.1016\/j.lpm.2021.104092_bib0036","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International pediatric multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2021.104092_bib0037","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3389\/fneur.2018.01156","article-title":"Predictors of evolution into multiple sclerosis after a first acute demyelinating syndrome in children and adolescents","volume":"9","author":"Papetti","year":"2018","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104092_bib0038","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-510X(99)00072-6","article-title":"Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis","volume":"165","author":"Pradhan","year":"1999","journal-title":"J Neurol Sci"},{"issue":"11","key":"10.1016\/j.lpm.2021.104092_bib0039","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s00415-007-0561-4","article-title":"Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg","volume":"254","author":"Ravaglia","year":"2007","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104092_bib0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","article-title":"Plasma exchange for severe attacks of CNS demyelination: predictors of response","volume":"58","author":"Keegan","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.lpm.2021.104092_bib0041","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104092_bib0042","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"issue":"16","key":"10.1016\/j.lpm.2021.104092_bib0043","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.lpm.2021.104092_bib0044","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104092_bib0045","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3174\/ajnr.A5593","article-title":"Brain MRI characteristics of patients with Anti-N-Methyl-D-Aspartate receptor encephalitis and their associations with 2-Year clinical outcome","volume":"39","author":"Zhang","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104092_bib0046","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/MD.0b013e318224b5af","article-title":"Rhombencephalitis: a series of 97 patients","volume":"90","author":"Moragas","year":"2011","journal-title":"Medicine (Baltimore) (Baltimore)"},{"issue":"4","key":"10.1016\/j.lpm.2021.104092_bib0047","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0034-1390387","article-title":"Neurosarcoidosis","volume":"34","author":"Agnihotri","year":"2014","journal-title":"Semin Neurol"},{"issue":"9","key":"10.1016\/j.lpm.2021.104092_bib0048","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1093\/brain\/awx200","article-title":"Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)","volume":"140","author":"Tobin","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2021.104092_bib0049","doi-asserted-by":"crossref","unstructured":"Sharif-Alhoseini, M., V. Rahimi-Movaghar, and A. Vaccaro, Underlying causes of paresthesia. 2012.","DOI":"10.5772\/32360"},{"issue":"4","key":"10.1016\/j.lpm.2021.104092_bib0050","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/brain\/88.4.663","article-title":"Observations on multiple sclerosis and conversion hysteria","volume":"88","author":"ARING","year":"1965","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.lpm.2021.104092_bib0051","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jnnp.68.2.207","article-title":"Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics","volume":"68","author":"Carson","year":"2000","journal-title":"J Neurol Neurosurg amp; Psychiatry"},{"issue":"1","key":"10.1016\/j.lpm.2021.104092_bib0052","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00415-011-6111-0","article-title":"Which neurological diseases are most likely to be associated with \u201csymptoms unexplained by organic disease","volume":"259","author":"Stone","year":"2012","journal-title":"J Neurol"},{"issue":"23","key":"10.1016\/j.lpm.2021.104092_bib0053","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1001\/jama.1980.03300490036024","article-title":"Multiple sclerosis and hysteria: lessons learned from their association","volume":"243","author":"Caplan","year":"1980","journal-title":"JAMA"},{"issue":"7527","key":"10.1016\/j.lpm.2021.104092_bib0054","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(67)91909-5","article-title":"The functional overlay","volume":"2","author":"Carter","year":"1967","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.lpm.2021.104092_bib0055","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1176\/ajp.2006.163.9.1510","article-title":"Conversion disorder","volume":"163","author":"Stonnington","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"9","key":"10.1016\/j.lpm.2021.104092_bib0056","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nrneurol.2017.106","article-title":"The tension between early diagnosis and misdiagnosis of multiple sclerosis","volume":"13","author":"Solomon","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104092_bib0057","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1148\/rg.2016160031","article-title":"White matter diseases with radiologic-pathologic correlation","volume":"36","author":"Sarbu","year":"2016","journal-title":"Radiographics"},{"issue":"12","key":"10.1016\/j.lpm.2021.104092_bib0058","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/jnnp.2006.110361","article-title":"Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study","volume":"78","author":"Verdelho","year":"2007","journal-title":"J Neurol Neurosurg amp Psychiatry"},{"issue":"15","key":"10.1016\/j.lpm.2021.104092_bib0059","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/WNL.0b013e3182a8235b","article-title":"Migraine and white matter hyperintensities: the ARIC MRI study","volume":"81","author":"Hamedani","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.lpm.2021.104092_bib0060","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1161\/01.STR.25.2.318","article-title":"Magnetic resonance abnormalities and cardiovascular disease in older adults. The cardiovascular health study","volume":"25","author":"Manolio","year":"1994","journal-title":"Stroke"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:07:55Z","timestamp":1760105275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498221000294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0755498221000294"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104092","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential diagnosis of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104092"}}